SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 48.55
-0.15 (-0.31%)
Jan 2, 2026, 1:35 PM CST
SCI Pharmtech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 115.35 | 534.68 | 294.72 | 308.78 | 55.7 | 360.12 | Upgrade |
Depreciation & Amortization | 250.17 | 233.79 | 145.29 | 90.61 | 63.71 | 133.3 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | 0.58 | 1.33 | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -2.08 | -3.62 | 1.87 | 14.07 | -2.24 | 15.71 | Upgrade |
Loss (Gain) on Equity Investments | 44.43 | 23.73 | 13.84 | 12.56 | 13.55 | - | Upgrade |
Stock-Based Compensation | - | - | 18.72 | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | - | - | - | - | - | -1.18 | Upgrade |
Other Operating Activities | -21.28 | 42.91 | 64.17 | -22.27 | -111.43 | 495 | Upgrade |
Change in Accounts Receivable | 17.86 | 17.86 | -133.8 | -90.59 | 254.77 | 15.83 | Upgrade |
Change in Inventory | -73.28 | -91.36 | -16.1 | -219.25 | 86.7 | -29.36 | Upgrade |
Change in Accounts Payable | 81.27 | 14.19 | -4.39 | 14.86 | -47.1 | -13.42 | Upgrade |
Change in Unearned Revenue | 10.39 | 56.56 | 6.59 | -9.99 | -55.53 | 38.2 | Upgrade |
Change in Other Net Operating Assets | 526.95 | 31.79 | -175.74 | 196.45 | 22.15 | -42.68 | Upgrade |
Operating Cash Flow | 949.78 | 860.52 | 215.77 | 296.57 | 280.28 | 971.53 | Upgrade |
Operating Cash Flow Growth | 888.24% | 298.82% | -27.25% | 5.81% | -71.15% | 22.73% | Upgrade |
Capital Expenditures | -1,027 | -946.64 | -1,029 | -1,168 | -771.03 | -217.7 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 0.07 | - | 0.07 | Upgrade |
Sale (Purchase) of Intangibles | -0.12 | - | - | - | -3.95 | - | Upgrade |
Investment in Securities | 7.88 | -62.42 | 163.27 | 156.03 | 237.42 | -217.64 | Upgrade |
Other Investing Activities | -0.55 | -0.3 | -0.11 | 2.4 | -2 | 6.27 | Upgrade |
Investing Cash Flow | -1,020 | -1,009 | -866.2 | -1,009 | -539.56 | -428.99 | Upgrade |
Short-Term Debt Issued | - | - | 63 | 112 | - | - | Upgrade |
Long-Term Debt Issued | - | 141.79 | 430.81 | 435.77 | - | - | Upgrade |
Total Debt Issued | 159 | 141.79 | 493.81 | 547.77 | - | - | Upgrade |
Short-Term Debt Repaid | - | -174.9 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -28.57 | -1.89 | -1.65 | -1.77 | -2.05 | Upgrade |
Total Debt Repaid | -359.97 | -203.47 | -1.89 | -1.65 | -1.77 | -2.05 | Upgrade |
Net Debt Issued (Repaid) | -200.97 | -61.68 | 491.91 | 546.12 | -1.77 | -2.05 | Upgrade |
Issuance of Common Stock | - | - | 957.6 | - | - | - | Upgrade |
Common Dividends Paid | -179.26 | -149.39 | -23.85 | - | -39.74 | -461.01 | Upgrade |
Other Financing Activities | 0.24 | 0.23 | - | 1 | - | - | Upgrade |
Financing Cash Flow | -379.99 | -210.84 | 1,426 | 547.12 | -41.52 | -463.06 | Upgrade |
Net Cash Flow | -450.36 | -359.68 | 775.23 | -165.4 | -300.8 | 79.47 | Upgrade |
Free Cash Flow | -77.59 | -86.12 | -813.59 | -871.02 | -490.75 | 753.83 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | 27.32% | Upgrade |
Free Cash Flow Margin | -5.58% | -5.65% | -67.56% | -96.81% | -56.79% | 28.03% | Upgrade |
Free Cash Flow Per Share | -0.65 | -0.72 | -7.42 | -8.10 | -4.57 | 6.98 | Upgrade |
Cash Interest Paid | 4.19 | 5.54 | 6.29 | 1.07 | 0.04 | 0.04 | Upgrade |
Cash Income Tax Paid | 18.16 | 72.31 | 4.93 | 0.11 | 115.85 | 166.79 | Upgrade |
Levered Free Cash Flow | -271.15 | -402.39 | -1,198 | -1,165 | -458.68 | 741.87 | Upgrade |
Unlevered Free Cash Flow | -268.53 | -398.93 | -1,194 | -1,165 | -458.65 | 741.9 | Upgrade |
Change in Working Capital | 563.19 | 29.02 | -323.43 | -108.53 | 260.99 | -31.43 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.